TickerFacts.

Taysha Gene Therapies, Inc. (TSHA): Long-Term Debt

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$37.97M
As of 2022-12-31
2021-12-31: $37.19M2022-12-31: $37.97M$37.97M
2021-12-31 Long-Term Debt (USD) 2022-12-31
Period endedLong-Term DebtChange YoYSource filing
2022-12-31$37.97M+2.1%2023-03-28, Balance as of period end
2021-12-31$37.19Mn/a2022-03-31, Balance as of period end